First National Bank & Trust Co. of Newtown Has $381,000 Stock Holdings in The Cigna Group (NYSE:CI)

First National Bank & Trust Co. of Newtown decreased its position in The Cigna Group (NYSE:CI) by 5.0% in the 4th quarter, HoldingsChannel reports. The fund owned 1,379 shares of the health services provider’s stock after selling 72 shares during the period. First National Bank & Trust Co. of Newtown’s holdings in The Cigna Group were worth $381,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Collier Financial acquired a new position in shares of The Cigna Group in the fourth quarter valued at $32,000. ORG Wealth Partners LLC bought a new stake in The Cigna Group in the 4th quarter valued at $34,000. Prospera Private Wealth LLC bought a new stake in The Cigna Group in the 3rd quarter valued at $37,000. Compagnie Lombard Odier SCmA acquired a new position in shares of The Cigna Group in the 4th quarter valued at $37,000. Finally, Harbor Capital Advisors Inc. bought a new position in shares of The Cigna Group during the 3rd quarter worth about $45,000. Institutional investors own 86.99% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. UBS Group lowered their target price on shares of The Cigna Group from $410.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, February 3rd. Barclays dropped their target price on The Cigna Group from $420.00 to $339.00 and set an “overweight” rating for the company in a report on Friday, January 31st. Truist Financial decreased their price target on The Cigna Group from $390.00 to $375.00 and set a “buy” rating on the stock in a research note on Tuesday, February 4th. Raymond James reiterated a “strong-buy” rating and set a $360.00 price objective (down from $415.00) on shares of The Cigna Group in a research note on Friday, January 31st. Finally, Stephens cut their price objective on The Cigna Group from $410.00 to $380.00 and set an “overweight” rating for the company in a report on Friday, January 31st. Two analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $373.69.

The Cigna Group Price Performance

CI opened at $297.27 on Thursday. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The stock has a market capitalization of $82.69 billion, a P/E ratio of 24.29, a price-to-earnings-growth ratio of 0.96 and a beta of 0.54. The company’s 50 day simple moving average is $285.65 and its 200-day simple moving average is $319.92. The Cigna Group has a one year low of $262.03 and a one year high of $370.83.

The Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period in the prior year, the business earned $6.79 earnings per share. Sell-side analysts anticipate that The Cigna Group will post 29.77 earnings per share for the current fiscal year.

The Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th will be issued a dividend of $1.51 per share. This is a boost from The Cigna Group’s previous quarterly dividend of $1.40. This represents a $6.04 annualized dividend and a yield of 2.03%. The ex-dividend date is Wednesday, March 5th. The Cigna Group’s payout ratio is currently 49.35%.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.